VRUS
Pharmasset Inc
Clinical-stage pharmaceutical company developing oral therapeutics for viral infections, notably hepatitis C (HCV)
CUSIP: 71715N106HealthcareUS1 holder
Total Value
$821.0K
Total Shares
83.6K
Net Share Change
+83.6K
Activity
1 buying
Investor
Value
Shares
Weight
Change
